Skip to Main Content
Apollo Therapeutics
  • Company
  • About
  • Team
  • Contact
  • News

News

Press Releases

November 14, 2022

Apollo Therapeutics and The Institute of Cancer Research enter into collaboration for cancer drug development

August 1, 2022

Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics

February 22, 2022

Apollo Therapeutics and King’s College London enter into a strategic collaboration

Recent Press

August 1, 2022

Apollo lands inflammatory antibody from Avalo for $90M biobucks

Endpoints | June 17, 2021

A UK biotech looks to bring alliance between GSK, J&J, AstraZeneca, and top universities stateside with its first megaround

Fiercebiotech | June 17, 2021

Apollo Therapeutics to go ‘full throttle’ with $145M raise after 5 years under the radar

Website built by: 3 Media Web Solutions, Inc. ©2023 Apollo Therapeutics | All Rights Reserved.
Privacy and Cookies Policy
info@apollotherapeutics.com